Interestingly, upon analysis of The Cancer Genome Atlas “TCGA” data28, FH was copy number amplified in over 40% of breast cancer patient samples and 15% of lung cancer patient samples (Supplementary Fig. 5A). This evidence concerns the gene FH and lung carcinoma.